Yeh Ming-Yang, Shih Yung-Luen, Chung Hsueh-Yu, Chou Jason, Lu Hsu-Feng, Liu Chia-Hui, Liu Jia-You, Huang Wen-Wen, Peng Shu-Fen, Wu Lung-Yuan, Chung Jing-Gung
Office of Director, Cheng Hsin General Hospital, Taipei, Taiwan, R.O.C.
Department of School of Medicine, Fu-Jen Catholic University, Taipei, Taiwan, R.O.C.; Department of Pathology and Laboratory Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taiwan, R.O.C.; School of Medical Laboratory Science and Biotechnology, Taipei Medical University, Taipei, Taiwan, R.O.C.
Exp Ther Med. 2016 Apr;11(4):1300-1306. doi: 10.3892/etm.2016.3057. Epub 2016 Feb 9.
Chitosan, a naturally derived polymer, has been shown to possess antimicrobial and anti-inflammatory properties; however, little is known about the effect of chitosan on the immune responses and glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT) and lactate dehydrogenase (LDH) activities in normal mice. The aim of the present study was to investigate whether chitosan has an effect on the immune responses and GOT, GPT and LDH activities in mice . BALB/c mice were divided into four groups. The negative control group was treated with a normal diet; the positive control group was treated with a normal diet plus orally administered acetic acid and two treatment groups were treated with a normal diet plus orally administered chitosan in acetic acid at doses of 5 and 20 mg/kg, respectively, every other day for 24 days. Mice were weighed during the treatment, and following the treatment, blood was collected, and liver and spleen samples were isolated and weighted. The blood samples were used for measurement of white blood cell markers, and the spleen samples were used for analysis of phagocytosis, natural killer (NK) cell activity and cell proliferation using flow cytometry. The results indicated that chitosan did not markedly affect the body, liver and spleen weights at either dose. Chitosan increased the percentages of CD3 (T-cell marker), CD19 (B-cell marker), CD11b (monocytes) and Mac-3 (macrophages) when compared with the control group. However, chitosan did not affect the phagocytic activity of macrophages in peripheral blood mononuclear cells, although it decreased it in the peritoneal cavity. Treatment with 20 mg/kg chitosan led to a reduction in the cytotoxic activity of NK cells at an effector to target ratio of 25:1. Chitosan did not significantly promote B-cell proliferation in lipopolysaccharide-pretreated cells, but significantly decreased T-cell proliferation in concanavalin A-pretreated cells, and decreased the activity of GOT and GPT compared with that in the acetic acid-treated group,. In addition, it significantly increased LDH activity, to a level similar to that in normal mice, indicating that chitosan can protect against liver injury.
壳聚糖是一种天然衍生的聚合物,已被证明具有抗菌和抗炎特性;然而,关于壳聚糖对正常小鼠免疫反应以及谷氨酸草酰乙酸转氨酶(GOT)、谷氨酸丙酮酸转氨酶(GPT)和乳酸脱氢酶(LDH)活性的影响,人们了解甚少。本研究的目的是调查壳聚糖是否对小鼠的免疫反应以及GOT、GPT和LDH活性有影响。将BALB/c小鼠分为四组。阴性对照组给予正常饮食;阳性对照组给予正常饮食并口服醋酸;两个治疗组分别给予正常饮食并每隔一天口服5毫克/千克和20毫克/千克醋酸壳聚糖,持续24天。在治疗期间对小鼠称重,治疗后采集血液,分离并称重肝脏和脾脏样本。血液样本用于测量白细胞标志物,脾脏样本用于通过流式细胞术分析吞噬作用、自然杀伤(NK)细胞活性和细胞增殖。结果表明,两种剂量的壳聚糖均未显著影响体重、肝脏和脾脏重量。与对照组相比,壳聚糖增加了CD3(T细胞标志物)、CD19(B细胞标志物)、CD11b(单核细胞)和Mac-3(巨噬细胞)的百分比。然而,壳聚糖虽降低了腹腔巨噬细胞的吞噬活性,但未影响外周血单核细胞中巨噬细胞的吞噬活性。用20毫克/千克壳聚糖处理导致效应细胞与靶细胞比例为25:1时NK细胞的细胞毒性活性降低。壳聚糖未显著促进脂多糖预处理细胞中的B细胞增殖,但显著降低了伴刀豆球蛋白A预处理细胞中的T细胞增殖,并且与醋酸处理组相比降低了GOT和GPT的活性。此外,它显著增加了LDH活性,使其达到与正常小鼠相似的水平,表明壳聚糖可以预防肝损伤。